
Overview
Louis Kavoussi, MD, MBA, Director of teleintervention at Northwell. He is a world-renowned urologic surgeon who brings more than 30 years of specialized expertise in minimally invasive urological surgery. His area of focus includes treating a wide range of urologic diseases, including kidney obstructions, renal stones and urologic cancer. At the forefront of innovation, Dr. Kavoussi pioneered several new surgical techniques, including the first minimally invasive approaches to kidney surgery for kidney cancer and kidney donation. He was also part of the team that performed the first laparoscopic prostate removal for cancer. In 1999, Dr. Kavoussi received a Smithsonian Computerworld Permanent Collection award for his work in developing telerounding, the starting point of telehealth medicine-to facilitate physician communication with hospitalized patients. Before joining Northwell in 2005 as chair of urology, Dr. Kavoussi completed his medical degree at the State University of New York at Buffalo. He obtained his urologic training at Washington University of St. Louis and, directly following residency, was named chief of urology at the Jewish Hospital of St. Louis. In 1991, he was appointed assistant professor at Harvard School of Medicine and director of endourology at the Brigham and Women's Hospital. In 1993, he joined the faculty of Johns Hopkins University School of Medicine, where he was vice chairman of urology and named a Patrick C. Walsh Distinguished Professor. Dr. Kavoussi values a team approach to care, and often collaborates with other specialists to create personalized and comprehensive treatment plans. His patients appreciate his easygoing personality and thoughtfulness. As the Waldbaum-Gardner Distinguished Professor of Urology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Dr. Kavoussi is passionate about training the next generation of surgeons. He has presented his work and given live surgical demonstrations at conferences around the world and has more than 500 academic publications.
Dr. Kavoussi is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery.
Dr. Kavoussi is board certified in American Board Of Urology. He is actively involved in clinical research, co-authoring 93 peer reviewed articles. Dr. Kavoussi is currently accepting new patients.
Specialties
Licenses
Board Certifications
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
450 Lakeville Road, Suite M42, Lake Success, NY 11042
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is highly rated in 48 conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. Kolitz is currently accepting new patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Nagashree Seetharamu, MD, MBBS, is an Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology, Medical Oncology and Hospice/Palliative medicine, she specializes in cancers of the head and neck and thoracic malignancies (lung cancer, mesothelioma, thymic tumors). She maintains an active clinical practice at the Monter Cancer Center where she focuses on providing compassionate, personalized, evidence-based multidisciplinary care. Dr. Seetharamu has established her reputation at the national level through her active involvement, and leadership within influential oncology organizations that steer the direction of clinical cancer care and research across the United States, and globally. She is a full member of both the Cancer Prevention Committee and Respiratory Committee of Alliance for Clinical Trials in Oncology. This is a national, NCI-sponsored, cooperative group that develops, fund and conducts clinical trials at many academic and community oncology centers across the country. In her position on these committees, she collaborates with clinical research experts across the country to establish standards-of-care, oversees the conduct of existing clinical trials, develops innovative and impactful hypotheses, and formulate future clinical trials. Dr. Seetharamu is the institutional principal investigator on over 10 clinical trials, has co-authored over 50 publications and book chapters and is a sought after speaker at various regional, national and international events related to Head and Neck and Thoracic cancer. Dr. Seetharamu is also Associate Program Director of the Medical Oncology and Hematology Fellowship Program for the Northwell Health Cancer Institute. In this role, she provides hands-on involvement in the recruitment, education and mentorship of future generations of physicians. Dr. Seetharamu trained in internal medicine at Long Island Jewish Medical Center and in hematology/oncology at New York University Medical Center. Dr. Seetharamu is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer. Dr. Seetharamu is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, American Board Of Internal Medicine/Hospice & Palliative Medicine, and American Board Of Internal Medicine/Hematology. Dr. Seetharamu is currently accepting new patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Veena John, MD, is the System Head for GYN/Medical Oncology for the Northwell Health Cancer Institute and an Assistant Professor of Medicine in the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Internal Medicine, Hematology and Medical Oncology, she maintains an active practice caring for patients with gynecologic cancers where she focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. In conjunction with physicians in Surgical Oncology, she pioneered a multi-disciplinary team approach for gynecologic oncology patients at the R.J. Zuckerberg Cancer Center where her practice is based. Dr. John is a highly experienced principal investigator for industry sponsored Phase I, II and III clinical trials in gynecologic oncology. She is the site principal investigator for the NRG cooperative group for the Northwell Health Cancer Institute and co-chair of the protocol review monitoring committee. Dr. John earned her medical degree from Christian Medical College in India, where she also completed her internal medicine internship. She completed her internal medicine residency at Flushing Medical Center and fellowship in hematology and medical oncology at North Shore University Hospital. She is an active member of the Society for Gynecologic Oncology, Society for Immunotherapy in Cancer, American Society of Clinical Oncology and American Society of Hematology as well as a member of the Ovarian Cancer committee for the national Gynecologic Oncology Group. Dr. John is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Testicular Yolk Sac Tumor, and Malignant Mixed Mullerian Tumor. Dr. John is board certified in American Board Of Internal Medicine/Medical Oncology, American Board Of Internal Medicine, and American Board Of Internal Medicine/Hematology. Dr. John is currently accepting new patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Douglas Gladstone is an Oncologist and a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Gladstone is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Hairy Cell Leukemia (HCL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Gladstone is currently accepting new patients.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
The Chronic Lymphocytic Leukemia (CLL) Research and Treatment Program has become a landmark for CLL patients worldwide. Dr. Kanti Rai has been involved in diagnosing and treating CLL for almost 40 years and the staging system that bears his name came out of his early breakthrough research. His particular areas of interest are: natural history of CLL, improving prognostic features of this disease and developing newer strategies of therapy which are hypothesis-driven. Dr. Rai is an active member of the International Workshop on CLL (iwCLL) and Dr. Keating s Global CLL Foundation. He is an active member of the American Society of Clinical Oncology (ASCO), American Association for Cancer Research (AACR) and the American Society of Hematology (ASH). In 2006, Dr. Rai served as the President of ASH. He was the recipient of ASCO s David Karnofsky Memorial Award in 2012. In 2013, Dr. Rai was honored with the iwCLL David Galton award. In 2014 he was presented with ASH s Wallace H. Coulter Lifetime Achievement Award. Dr. Rai is the Joel Finkelstein Cancer Foundation Professor of Medicine, and Professor of Molecular Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell School of Medicine and Professor of Medicine at the Feinstein Institute for Medical Research, Manhasset, NY. Dr. Rai is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Leukemia, and Richter Syndrome. Dr. Rai is board certified in American Board Of Pediatrics. Dr. Rai is currently accepting new patients.
Winthrop University Hospital
Anthony Corcoran is an Oncologist practicing medicine in Mineola, New York. Dr. Corcoran is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Muscle Invasive Bladder Cancer, Prostate Cancer, Renal Cell Carcinoma (RCC), Nephrectomy, and Reconstructive Urology Surgery.
Frequently Asked Questions about Dr. Louis R. Kavoussi
How do I make an appointment with Dr. Louis R. Kavoussi?
You can book an appointment with Dr. Louis R. Kavoussi by calling their office at 516-734-8500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Louis R. Kavoussi a top-rated expert for Nephrectomy?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Louis R. Kavoussi is classified as an Elite expert for Nephrectomy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Louis R. Kavoussi specialize in?
While Dr. Louis R. Kavoussi is a Oncology, they have specific expertise in Nephrectomy, Renal Cell Carcinoma (RCC), and Chromophobe Renal Cell Carcinoma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Louis R. Kavoussi participate in research or clinical trials?
Yes. Dr. Louis R. Kavoussi has published 93 articles and abstracts on conditions like Nephrectomy. You can view a list of Dr. Louis R. Kavoussi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Louis R. Kavoussi accept my insurance?
Dr. Louis R. Kavoussi accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 516-734-8500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- NephrectomyDr. Kavoussi isElite. Learn about Nephrectomy.
- Renal Cell Carcinoma (RCC)Dr. Kavoussi isElite. Learn about Renal Cell Carcinoma (RCC).
- Distinguished
- Adult Soft Tissue SarcomaDr. Kavoussi isDistinguished. Learn about Adult Soft Tissue Sarcoma.
- Chromophobe Renal Cell CarcinomaDr. Kavoussi isDistinguished. Learn about Chromophobe Renal Cell Carcinoma.
- Clear Cell SarcomaDr. Kavoussi isDistinguished. Learn about Clear Cell Sarcoma.
- Familial Wilms Tumor 2Dr. Kavoussi isDistinguished. Learn about Familial Wilms Tumor 2.
- Muscle Invasive Bladder CancerDr. Kavoussi isDistinguished. Learn about Muscle Invasive Bladder Cancer.
- Prostate CancerDr. Kavoussi isDistinguished. Learn about Prostate Cancer.
- Upper Tract Urothelial Carcinoma (UTUC)Dr. Kavoussi isDistinguished. Learn about Upper Tract Urothelial Carcinoma (UTUC).
- Wilms TumorDr. Kavoussi isDistinguished. Learn about Wilms Tumor.
- WT1-Related Wilms Tumor SyndromesDr. Kavoussi isDistinguished. Learn about WT1-Related Wilms Tumor Syndromes.
- Advanced
- Bladder CancerDr. Kavoussi isAdvanced. Learn about Bladder Cancer.
- BoilsDr. Kavoussi isAdvanced. Learn about Boils.
- CarbuncleDr. Kavoussi isAdvanced. Learn about Carbuncle.
- EndoscopyDr. Kavoussi isAdvanced. Learn about Endoscopy.
- Familial Prostate CancerDr. Kavoussi isAdvanced. Learn about Familial Prostate Cancer.
- FolliculitisDr. Kavoussi isAdvanced. Learn about Folliculitis.
- Non-Muscle Invasive Bladder CancerDr. Kavoussi isAdvanced. Learn about Non-Muscle Invasive Bladder Cancer.
- ProstatectomyDr. Kavoussi isAdvanced. Learn about Prostatectomy.
- Reconstructive Urology SurgeryDr. Kavoussi isAdvanced. Learn about Reconstructive Urology Surgery.
- Renal OncocytomaDr. Kavoussi isAdvanced. Learn about Renal Oncocytoma.
- UreteroscopyDr. Kavoussi isAdvanced. Learn about Ureteroscopy.
- Urothelial CancerDr. Kavoussi isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Adrenal CancerDr. Kavoussi isExperienced. Learn about Adrenal Cancer.
- Biliary DyskinesiaDr. Kavoussi isExperienced. Learn about Biliary Dyskinesia.
- Bladder ReconstructionDr. Kavoussi isExperienced. Learn about Bladder Reconstruction.
- Gallbladder DiseaseDr. Kavoussi isExperienced. Learn about Gallbladder Disease.
- Hereditary NeuroblastomaDr. Kavoussi isExperienced. Learn about Hereditary Neuroblastoma.
- Hereditary Paraganglioma-Pheochromocytoma Syndrome
- Hernia SurgeryDr. Kavoussi isExperienced. Learn about Hernia Surgery.
- NeuroblastomaDr. Kavoussi isExperienced. Learn about Neuroblastoma.
- PheochromocytomaDr. Kavoussi isExperienced. Learn about Pheochromocytoma.
- Pudendal NeuralgiaDr. Kavoussi isExperienced. Learn about Pudendal Neuralgia.
- Retroperitoneal LiposarcomaDr. Kavoussi isExperienced. Learn about Retroperitoneal Liposarcoma.




